Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06117241 · ClinicalTrials.gov registry record · NA

Reducing Metabolic Dysregulation in Dyads

A NA study of Colorectal Cancer and Inflammation, sponsored by University of South Carolina.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06117241: Recruiting NA study of Colorectal Cancer and Inflammation, sponsored by University of South Carolina.

NCT06117241 is a NA study of Colorectal Cancer and Inflammation that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 180 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06117241, a NA study of Colorectal Cancer and Inflammation, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This study is a 6-month randomized controlled trail of diet modification designed to reduce chronic inflammation and reverse metabolic dysfunction among obese individuals with one or more polyps found at a colonoscopy screening. We also will recruit an at least overweight partner, who lives in the same household. To be eligible, participants will be apparently disease-free, obese AAs or EAs who have self-identified a partner who is at least 9 years, with whom they live and who also is at least overweight. Each index participant will: 1) Be AA or EA by self-report; 2) Be ≤55 years old; 3) Have undergone a colonoscopy screening and found to have ≥1 polyp(s); 4) Be free of co-morbid conditions or other factors that would limit participation in this trial; 5) Have a BMI ≥30kg/m2; 6) Be willing to commit to investing the time and effort required to participate in this trial (i.e., willing to complete all assessments and provide biological samples as specified in the consent); and 7) Have no recent antibiotic use. Their partner needs to: 1) Be at least 9 years old; 2) Live in the same household and consumes meals together; 3) Be at least overweight; 4) Agree to all study procedures, including provision of biological samples, body measurements, and self-reported dietary and other assessments; and 5) Have no recent antibiotic use.

Primary Outcome

Tumor Necrosis Factor alpha (TNFα), Interleukin 6 (IL-6), and C-Reactive Protein (CRP)

Interventions

  • BEHAVIORAL IMAGINE HEALTHY

Study Locations (1)

South Carolina

  • University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-10-17
Est. Completion 2028-03-31
Phase NA
University of South Carolina

157 total trials

What NCT06117241 shows while recruiting

NCT06117241 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which IMAGINE HEALTHY is the first listed.

NCT06117241 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06117241 about?

NCT06117241 is a clinical study titled "Reducing Metabolic Dysregulation in Dyads". This study is a 6-month randomized controlled trail of diet modification designed to reduce chronic inflammation and reverse metabolic dysfunction among obese individuals with one or more polyps found at a colonoscopy screening. We also will recruit an at least overweight partner, who lives in the s...

What is the current status of trial NCT06117241?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-10-17. Estimated completion is 2028-03-31.

What conditions does trial NCT06117241 study?

This clinical trial studies the following conditions: Colorectal Cancer, Inflammation, Nutrition Related Cancer.

What interventions are being tested in trial NCT06117241?

The interventions under investigation include: IMAGINE HEALTHY (BEHAVIORAL).

Who is sponsoring clinical trial NCT06117241?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06117241 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06117241's enrollment target sits among peer trials

180 156th of 381 higher than 223 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06117241, the US trial registry maintained by the National Library of Medicine. NCT06117241 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.